Featuring perspectives from Dr Alexander Spira, including the following topics:
- KRAS mutations in patients with non-small cell lung cancer (NSCLC) (0:00)
- KRAS small-molecule inhibitors combined with targeted therapy or immunotherapy for patients with NSCLC (3:49)
- KRAS small-molecule inhibitors in patients with NSCLC and brain metastases (10:52)
- Future role of KRAS small-molecule inhibitors as adjuvant or neoadjuvant therapy for patients with localized NSCLC (12:21)
- Comparing and contrasting KRAS small-molecule inhibitors for NSCLC (14:56)
- Future directions in targeting KRAS and other mutations (20:32)
- Using liquid biopsy to detect KRAS-mutated NSCLC (33:01)
- Common misperceptions about targeting KRAS G12C in NSCLC (35:43)
CME information and select publications
Research To Practice | Oncology Videos